Toronto, August 19, 2025 – Dr. Allison Sekuler, a pioneering figure in cognitive neuroscience and the President and Chief Scientist of Baycrest Academy for Research and Education as well as the Centre for Aging + Brain Health Innovation (CABHI) powered by Baycrest, has been honored with election as a Fellow of the Canadian Academy of Health Sciences (CAHS). This distinction stands among the most prestigious accolades in Canadian health sciences, recognizing exceptional leadership, groundbreaking scientific contributions, and a sustained commitment to enhancing health outcomes on a national scale.
The Canadian Academy of Health Sciences Fellowship acknowledges individuals whose work demonstrates profound impact in advancing health science and improving public health policy and practice. Dr. Sekuler’s election reflects her extensive achievements in neuroscience research, especially relating to aging and brain health, alongside her leadership in scientific innovation. Her work exemplifies the integration of empirical research with translational applications, a hallmark of CAHS’s mission to promote health science excellence.
Dr. Sekuler’s research intricately dissects how the human brain processes complex visual stimuli. Using advanced behavioral assays coupled with sophisticated neuroimaging techniques such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG), her laboratory has illuminated the neurobiological substrates underlying sensory and cognitive decline in aging populations. Notably, her investigations were among the first to demonstrate the plasticity of the aging brain, revealing mechanisms through which neural circuits reconfigure to compensate for degenerative changes.
Her contributions have broad implications spanning early detection and intervention in dementia, where subtle deficits in sensory processing can serve as precursors to cognitive impairment. By leveraging multimodal imaging and continuous behavioral assessment, Dr. Sekuler’s work elucidates early biomarkers capable of predicting neurodegenerative trajectories. This predictive power equips clinicians and researchers with tools to design personalized therapeutic strategies and interventions aimed at mitigating the progression of age-related cognitive disorders.
Beyond her empirical research, Dr. Sekuler’s leadership extends to fostering innovation ecosystems that bridge basic science, clinical application, and community impact. At Baycrest, she spearheads initiatives focused on marrying cutting-edge technology with patient-centered care models. The Centre for Aging + Brain Health Innovation exemplifies this approach, aggregating interdisciplinary expertise to accelerate the translation of neurocognitive research into scalable solutions addressing the global aging crisis.
Her dual faculty appointments at the University of Toronto and McMaster University further underscore her commitment to academic mentorship and pedagogy. By cultivating the next generation of neuroscientists and clinicians, Dr. Sekuler fosters an environment where empirical rigour and translational ambition coalesce. Her prolific publication record, with articles appearing in premier journals such as Nature, Current Biology, and The Journal of Neuroscience, reflects both the depth and breadth of her scientific influence.
In the realm of public engagement, Dr. Sekuler proactively disseminates knowledge through multiple platforms. She co-hosts Baycrest’s Defy Dementia podcast, which translates complex neuroscientific concepts for broad audiences, demystifying aging and brain health challenges. Additionally, her role on advisory boards, including the Canadian Brain Research Strategy and international consortia on artificial intelligence and society, positions her at the nexus of cutting-edge interdisciplinary collaboration.
A staunch advocate for equity and inclusion in science, Dr. Sekuler co-founded Females of Vision et al. (FoVea), a network dedicated to supporting women researchers in vision science fields. Her leadership in anti-racism initiatives within the Ontario Hospital Association’s Research and Innovation Anti-Racism Taskforce highlights her commitment to creating diverse, equitable environments that nurture scientific creativity and social responsibility.
Her remarkable career has earned her recognition as Canada’s inaugural Canada Research Chair in Cognitive Neuroscience, a testament to her academic excellence and pioneering spirit. Moreover, her repeated designation as one of WXN’s Top 100 Most Powerful Women in Canada — most recently in 2024 — attests to her influential role not only in science but also in shaping healthcare innovation and policy.
Baycrest’s vision—to create a world where older adults live with purpose, dignity, and fulfillment—is reflected in Dr. Sekuler’s work. The institution itself, with over a century of expertise in senior care and brain health research, serves as a critical hub for innovation. Through entities like CABHI and the Canadian Consortium on Neurodegeneration in Aging, Baycrest stands at the forefront of efforts to decode the complexities of aging biology and translate discoveries into improved clinical outcomes.
Affiliated with the University of Toronto, Baycrest’s educational programs advance global standards in elder care, training specialists equipped to meet emerging challenges of aging populations worldwide. Further, Baycrest Global Solutions leverages this expertise to assist international healthcare and senior living organizations in implementing evidence-based strategies that enhance quality of life for older adults.
Dr. William Reichman, President and CEO of Baycrest Seniors Care, articulated the community’s pride in Dr. Sekuler’s achievement, emphasizing how her groundbreaking research continues to push boundaries in brain health. His statement underscores how individual excellence feeds into broader institutional missions, catalyzing knowledge generation and practical advances that resonate across both national and international domains.
The recognition of Dr. Allison Sekuler by the Canadian Academy of Health Sciences solidifies her status as a luminary in cognitive neuroscience and aging research. Her ongoing commitment to innovation, equity, and public engagement ensures that her influence extends beyond laboratories and academic journals into the lived experiences of older adults worldwide. As global populations age, such visionary leadership is indispensable in tackling the multifaceted challenges posed by cognitive decline and neurodegenerative diseases.
This accolade as a CAHS Fellow not only honors past achievements but also heralds a promising trajectory for future discoveries and advancements under Dr. Sekuler’s stewardship. Her integrated approach, combining rigorous science with humanistic care, epitomizes the evolving paradigm in health sciences—one where precision, empathy, and social responsibility intersect to foster healthier, more vibrant aging trajectories.
For comprehensive details on the Canadian Academy of Health Sciences and the full roster of 2025 Fellows, visit the official website at cahs-acss.ca/2025-elected-fellows/.
Subject of Research: Cognitive neuroscience of aging, brain plasticity, early detection and treatment of dementia, sensory and cognitive decline.
Article Title: Dr. Allison Sekuler Elected Fellow of the Canadian Academy of Health Sciences for Pioneering Contributions to Brain Health and Aging Research
News Publication Date: August 19, 2025
Web References: https://cahs-acss.ca/2025-elected-fellows/
Image Credits: Courtesy of Baycrest
Keywords: Research impact, Brain, Cognitive neuroscience, Aging, Dementia, Neuroimaging, Brain plasticity, Sensory processing, Health sciences, Innovation, Equity in science, Public engagement
